Amneal Pharmaceuticals Recalls Vancomycin Hydrochloride for Oral Solution USP, 250 mg/5 mL
PharmaTech
MARCH 30, 2024
The company is voluntarily recalling the product for potential super potent bottles due to overfilling.
PharmaTech
MARCH 30, 2024
The company is voluntarily recalling the product for potential super potent bottles due to overfilling.
Pharmacy Times
MARCH 30, 2024
Investigators identify 32 performance measures in the final set grouped into 10 categories of disease or health condition.
PharmaTech
MARCH 30, 2024
FDA granted fast track designation to nipocalimab, which J&J is developing for helping alloimmunized pregnant adults treat FNAIT, a rare disease that poses risk to the fetus or newborn.
Let's personalize your content